» Articles » PMID: 22270722

Magnetic Resonance Imaging of Glutamate

Overview
Journal Nat Med
Date 2012 Jan 25
PMID 22270722
Citations 342
Authors
Affiliations
Soon will be listed here.
Abstract

Glutamate, a major neurotransmitter in the brain, shows a pH- and concentration-dependent chemical exchange saturation transfer effect (GluCEST) between its amine group and bulk water, with potential for in vivo imaging by nuclear magnetic resonance. GluCEST asymmetry is observed ∼3 p.p.m. downfield from bulk water. Middle cerebral artery occlusion in the rat brain resulted in an ∼100% elevation of GluCEST in the ipsilateral side compared with the contralateral side, predominantly owing to pH changes. In a rat brain tumor model with blood-brain barrier disruption, intravenous glutamate injection resulted in a clear elevation of GluCEST and a similar increase in the proton magnetic resonance spectroscopy signal of glutamate. GluCEST maps from healthy human brain were also obtained. These results demonstrate the feasibility of using GluCEST for mapping relative changes in glutamate concentration, as well as pH, in vivo. Contributions from other brain metabolites to the GluCEST effect are also discussed.

Citing Articles

Going Above and Beyond: Achieving High Contrast and Higher Offset through Carbon Dot-Based diaCEST MRI Contrast Agent.

Pandey S, Ghosh A Chem Biomed Imaging. 2025; 3(2):123-131.

PMID: 40018648 PMC: 11863154. DOI: 10.1021/cbmi.4c00086.


Mapping hippocampal glutamate in healthy aging with glutamate-weighted CEST (GluCEST) imaging.

Pecsok M, Robinson H, Atkins A, Calkins M, Elliott M, Mordy A Front Aging Neurosci. 2025; 16:1535158.

PMID: 39926356 PMC: 11802501. DOI: 10.3389/fnagi.2024.1535158.


Molecular imaging of viral pathogenesis and opportunities for the future.

Kelly B, Boudreau J, Beyea S, Brewer K Npj Imaging. 2025; 3(1):3.

PMID: 39872292 PMC: 11761071. DOI: 10.1038/s44303-024-00056-w.


CEST imaging combined with H-MRS reveal the neuroprotective effects of riluzole by improving neurotransmitter imbalances in Alzheimer's disease mice.

Shen Y, Zhang X, Liu S, Xin L, Xuan W, Zhuang C Alzheimers Res Ther. 2025; 17(1):20.

PMID: 39806490 PMC: 11726951. DOI: 10.1186/s13195-025-01672-3.


Research Progress on Glioma Microenvironment and Invasiveness Utilizing Advanced Multi-Parametric Quantitative MRI.

Song D, Fan G, Chang M Cancers (Basel). 2025; 17(1.

PMID: 39796702 PMC: 11719598. DOI: 10.3390/cancers17010074.


References
1.
Davalos A, Shuaib A, Wahlgren N . Neurotransmitters and pathophysiology of stroke: evidence for the release of glutamate and other transmitters/mediators in animals and humans. J Stroke Cerebrovasc Dis. 2007; 9(6 Pt 2):2-8. DOI: 10.1053/jscd.2000.18908. View

2.
Haris M, Cai K, Singh A, Hariharan H, Reddy R . In vivo mapping of brain myo-inositol. Neuroimage. 2010; 54(3):2079-85. PMC: 3013615. DOI: 10.1016/j.neuroimage.2010.10.017. View

3.
Tuor U, Meng S, Qiao M, Webster N, Crowley S, Dyck R . Differential progression of magnetization transfer imaging changes depending on severity of cerebral hypoxic-ischemic injury. J Cereb Blood Flow Metab. 2008; 28(9):1613-23. DOI: 10.1038/jcbfm.2008.49. View

4.
Gottschalk M, Lamalle L, Segebarth C . Short-TE localised 1H MRS of the human brain at 3 T: quantification of the metabolite signals using two approaches to account for macromolecular signal contributions. NMR Biomed. 2007; 21(5):507-17. DOI: 10.1002/nbm.1219. View

5.
Harrison P . Metabotropic glutamate receptor agonists for schizophrenia. Br J Psychiatry. 2008; 192(2):86-7. DOI: 10.1192/bjp.bp.107.045088. View